Contemporary OBGyn

CONTINUE TO SITE >

OR WAIT 15 SECS

Why a Women's Health Company?BV & Sexually Transmitted InfectionsCervical Cancer ScreeningCervical Cancer TodayCervical RipeningEndometriosisLaser Treatment for GSMLong Lasting Reversible ContraceptionMenopauseOsteoporosisSurgeryTB ScreeningUterine Fibroid

ContraceptionCOVID-19GynecologyLegally SpeakingLife TransitionsObstetricsVulvovaginalWell Woman

All NewsResidents CornerPractice Management

Medical World NewsQuizzes

Podcasts Videos

Conference CoverageConference Listing

Digital EditionDigital Supplements

CMEJob BoardSponsored Resources

eNewsletterPrint Subscription

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.

Spotlight

Why a Women's Health Company?
BV & Sexually Transmitted Infections
Cervical Cancer Screening
Cervical Cancer Today
Cervical Ripening
Endometriosis
Laser Treatment for GSM
Long Lasting Reversible Contraception
Menopause
Osteoporosis
Surgery
TB Screening
Uterine Fibroid

ClinicalSee All >

Contraception
COVID-19
Gynecology
Legally Speaking
Life Transitions
Obstetrics
Vulvovaginal
Well Woman

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences^™ and Contemporary OB/GYN. All rights reserved.

Fibroids and Conservative Treatment

November 26, 2007

Paul D. Indman, MD , Paul D. Indman, MD , Linda Bradley, MD

Conferences | AAGL

Coverage of 36th AAGL Congress November 2007, Washington, DC